 Receptors, Interleukin-1
"Receptors, Interleukin-1" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Cell surface receptors that are specific for INTERLEUKIN-1. Included under this heading are signaling receptors, non-signaling receptors and accessory proteins required for receptor signaling. Signaling from interleukin-1 receptors occurs via interaction with SIGNAL TRANSDUCING ADAPTOR PROTEINS such as MYELOID DIFFERENTIATION FACTOR 88.
| Descriptor ID |
D017472
|
| MeSH Number(s) |
D12.776.543.750.705.852.420.300
|
| Concept/Terms |
Receptors, Interleukin-1- Receptors, Interleukin-1
- Receptors, Interleukin 1
- IL1 Receptors
- Receptors, IL1
- Interleukin-1 Receptors
- Interleukin 1 Receptors
- Receptors, IL-1
- Receptors, IL 1
- IL-1 Receptors
- IL 1 Receptors
- Interleukin 1 Receptor
- Receptor, Interleukin 1
|
Below are MeSH descriptors whose meaning is more general than "Receptors, Interleukin-1".
Below are MeSH descriptors whose meaning is more specific than "Receptors, Interleukin-1".
This graph shows the total number of publications written about "Receptors, Interleukin-1" by people in this website by year, and whether "Receptors, Interleukin-1" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1988 | 0 | 1 | 1 | | 1989 | 0 | 7 | 7 | | 1990 | 0 | 3 | 3 | | 1991 | 0 | 9 | 9 | | 1992 | 5 | 10 | 15 | | 1993 | 9 | 7 | 16 | | 1994 | 8 | 4 | 12 | | 1995 | 6 | 2 | 8 | | 1996 | 3 | 2 | 5 | | 1997 | 5 | 6 | 11 | | 1998 | 6 | 2 | 8 | | 1999 | 5 | 4 | 9 | | 2000 | 3 | 0 | 3 | | 2001 | 1 | 4 | 5 | | 2002 | 3 | 0 | 3 | | 2003 | 2 | 2 | 4 | | 2004 | 2 | 3 | 5 | | 2005 | 2 | 5 | 7 | | 2006 | 3 | 1 | 4 | | 2007 | 0 | 4 | 4 | | 2009 | 2 | 4 | 6 | | 2010 | 2 | 2 | 4 | | 2011 | 0 | 2 | 2 | | 2012 | 3 | 0 | 3 | | 2013 | 2 | 1 | 3 | | 2014 | 5 | 3 | 8 | | 2015 | 4 | 1 | 5 | | 2016 | 2 | 2 | 4 | | 2017 | 0 | 2 | 2 | | 2018 | 1 | 0 | 1 |
To return to the timeline, click here.
Below are the most recent publications written about "Receptors, Interleukin-1" by people in Profiles.
-
Dinarello CA. Overview of the IL-1 family in innate inflammation and acquired immunity. Immunol Rev. 2018 01; 281(1):8-27.
-
Carey A, Edwards DK, Eide CA, Newell L, Traer E, Medeiros BC, Pollyea DA, Deininger MW, Collins RH, Tyner JW, Druker BJ, Bagby GC, McWeeney SK, Agarwal A. Identification of Interleukin-1 by Functional Screening as a Key Mediator of Cellular Expansion and Disease Progression in Acute Myeloid Leukemia. Cell Rep. 2017 03 28; 18(13):3204-3218.
-
Cavalli G, Justice JN, Boyle KE, D'Alessandro A, Eisenmesser EZ, Herrera JJ, Hansen KC, Nemkov T, Stienstra R, Garlanda C, Mantovani A, Seals DR, Dagna L, Joosten LA, Ballak DB, Dinarello CA. Interleukin 37 reverses the metabolic cost of inflammation, increases oxidative respiration, and improves exercise tolerance. Proc Natl Acad Sci U S A. 2017 02 28; 114(9):2313-2318.
-
Lewis SS, Grace PM, Hutchinson MR, Maier SF, Watkins LR. Constriction of the buccal branch of the facial nerve produces unilateral craniofacial allodynia. Brain Behav Immun. 2017 Aug; 64:59-64.
-
Gresnigt MS, Rekiki A, Rasid O, Savers A, Jouvion G, Dannaoui E, Parlato M, Fitting C, Brock M, Cavaillon JM, van de Veerdonk FL, Ibrahim-Granet O. Reducing hypoxia and inflammation during invasive pulmonary aspergillosis by targeting the Interleukin-1 receptor. Sci Rep. 2016 05 24; 6:26490.
-
Joosten LA, Abdollahi-Roodsaz S, Dinarello CA, O'Neill L, Netea MG. Toll-like receptors and chronic inflammation in rheumatic diseases: new developments. Nat Rev Rheumatol. 2016 06; 12(6):344-57.
-
Dinarello CA, Nold-Petry C, Nold M, Fujita M, Li S, Kim S, Bufler P. Suppression of innate inflammation and immunity by interleukin-37. Eur J Immunol. 2016 05; 46(5):1067-81.
-
Shakoory B, Carcillo JA, Chatham WW, Amdur RL, Zhao H, Dinarello CA, Cron RQ, Opal SM. Interleukin-1 Receptor Blockade Is Associated With Reduced Mortality in Sepsis Patients With Features of Macrophage Activation Syndrome: Reanalysis of a Prior Phase III Trial. Crit Care Med. 2016 Feb; 44(2):275-81.
-
Cavalli G, Dinarello CA. Treating rheumatological diseases and co-morbidities with interleukin-1 blocking therapies. Rheumatology (Oxford). 2015 Dec; 54(12):2134-44.
-
Rider P, Carmi Y, Yossef R, Guttman O, Eini H, Azam T, Dinarello CA, Lewis EC. IL-1 Receptor Antagonist Chimeric Protein: Context-Specific and Inflammation-Restricted Activation. J Immunol. 2015 Aug 15; 195(4):1705-12.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|